These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 20809665)

  • 1. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug-drug interactions and associated factors among hospitalized pediatric patients in Adigrat general hospital, Tigrai, north Ethiopia: a retrospective cross-sectional study.
    Hailesilase GG; Kidane AM; Gebrezgabiher HA
    BMC Pediatr; 2024 Oct; 24(1):652. PubMed ID: 39394093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
    Egger SS; Rätz Bravo AE; Hess L; Schlienger RG; Krähenbühl S
    Drugs Aging; 2007; 24(5):429-40. PubMed ID: 17503898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
    Noor S; Ismail M; Khadim F
    Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
    Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
    Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of prescription medications in home-based older adults with stroke: a pilot study.
    Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
    Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
    Noor S; Ismail M; Ali Z
    BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
    Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
    AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
    Noor S; Ismail M; Haider I; Khadim F
    Ann Hepatol; 2018 Oct; 17(6):1001-1011. PubMed ID: 30600298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
    Noor S; Ismail M; Khan F
    Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
    Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
    Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study.
    Liu Y; Yang M; Ding Y; Wang H; Zhang H; Wang D; Zhuang T; Ji M; Cui Y; Wang H
    BMC Psychiatry; 2022 Aug; 22(1):563. PubMed ID: 35996119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.
    Fokter N; Mozina M; Brvar M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):81-8. PubMed ID: 20213374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Drug-Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis.
    Navaratinaraja TS; Kumanan T; Siraj S; Sreeharan N
    Drugs Real World Outcomes; 2023 Mar; 10(1):83-95. PubMed ID: 36380216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of treatment choices on potential drug-drug interactions in hypertensive patients.
    Perić A; Udilović A; Dobrić S; Vezmar Kovačević S
    Br J Clin Pharmacol; 2022 May; 88(5):2340-2348. PubMed ID: 34862631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
    Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
    Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.